The North American injection pen market is anticipated to grow at a CAGR of 6.2% over the forecast period. The market is primarily driven by the presence of a large pool of diabetic patients in the region. As per the IDF, in North America, the prevalence of diabetes is approximately 13.3% of the total adult population in the region which is projected to reach up to 14.2% by 2030 and further...